Stockreport

Serina Therapeutics Provides Regulatory Update on SER-252 Program

Serina Therapeutics, Inc.  (SER) 
PDF - FDA requests additional information on a formulation component - HUNTSVILLE, AL, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE Americ [Read more]